4
Changes in Ownership
Cytosorbents Corp Filed Acc 0001104659-22-090254
Chief Medical Officer acquired 107,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Deliargyris Efthymios · Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-08-10 | Grant or award : show line 1 in the form | +55,000 | 228,384 | D |
| 2022-08-10 | Grant or award : show line 2 in the form | +52,000 | 283,384 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-08-10 | Grant or award : show line 3 in the form Stock Option (right to buy) | +74,000 | 74,000 | D |
| 2022-08-10 | Grant or award : show line 4 in the form Stock Option (right to buy) | +300,000 | 300,000 | D |
Loading xslF345X03/tm2223355-5_4seq1.xml…